BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold.EBI
University of Kansas Specialized Chemistry Center
Ion channels as therapeutic targets: a drug discovery perspective.EBI
Pfizer
Selective TASK-1 Inhibitor with a Defined Structure-Activity Relationship Reduces Cancer Cell Proliferation and Viability.EBI
Centro De Estudios En Alimentos Procesados-Ceap
TASK Channels Pharmacology: New Challenges in Drug Design.EBI
Universidad De Talca
Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitorsBDB
Bayer Pharma Aktiengesellschaft
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBDB
Bayer Aktiengesellschaft
2-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disordersBDB
Bayer Pharma Aktiengesellschaft
Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of sameBDB
Bayer Pharma Aktiengesellschaft